Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways

Cell Stress and Chaperones

Volumn 21, Issue 6, 2016, Pages 1037-1053

  Zhou, Jian Ming ^a   Gu, Sha Sha ^a   Mei, Wang Hong ^a   Zhou, Jun ^a   Wang, Zhen Zhong ^a   Xiao, Wei ^a  

^a Jiangsu Kanion Modern TCM Research Institute   (China)

Author keywords

Bilobalide; BV2 microglia cells; Cerebral ischemia; Ginkgolides; Inflammatory; NF B; TLRs

Indexed keywords

BILOBALIDE; CASPASE 3; GINKGOLIDE; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE K; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYCLOPENTANE DERIVATIVE; CYTOKINE; FURAN DERIVATIVE; GLUCOSE; MYD88 PROTEIN, MOUSE; RELA PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DOWN REGULATION; HYPOXIA; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REOXYGENATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CELL HYPOXIA; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; METABOLISM;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL LINE; CYCLOPENTANES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FURANS; GINKGOLIDES; GLUCOSE; MICE; MICROGLIA; MICROSCOPY, FLUORESCENCE; MYELOID DIFFERENTIATION FACTOR 88; NEUROPROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA;

EID: 84983418165     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-016-0728-y     Document Type: Article

References (96)

1. Ahlemeyer B, Krieglstein J (2003) Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci: CMLS 60:1779–1792
2. Akira S (2009) Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B, Phys Biol Sci 85:143–156
3. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511
4. Andrieu S, Ousset PJ, Coley N, Ouzid M, Mathiex-Fortunet H, Vellas B, G. Guid Age study (2008) GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer’s disease in elderly subjects with memory complaints. I. Rationale, design and baseline data. Curr Alzheimer Res 5:406–415
5. Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13–20
6. Boonyarat C, Yenjai C, Vajragupta O, Waiwut P (2014) Heptaphylline induces apoptosis in human colon adenocarcinoma cells through bid and Akt/NF-kappaB (p65) pathways. Asian Pac J Cancer Prev: APJCP 15:10483–10487
7. Braquet P (1986) Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res 16:179–198
8. Broughton BR, Reutens DC, Sobey CG (2009) Apoptotic mechanisms after cerebral ischemia. Stroke J Cereb Circ 40:e331–e339
9. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Chinopoulos C, Drieu K, Fiskum G (2003) Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry 36(Suppl 1):S89–S94
10. De Plaen IG, Tan XD, Chang H, Wang L, Remick DG, Hsueh W (2000) Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. Br J Pharmacol 129:307–314
11. Defeudis FV (2002) Bilobalide and neuroprotection. Pharmacol Res 46:565–568
12. Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB (1986) Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the Guinea-pig. Eur J Pharmacol 127:83–95
13. Dheen ST, Kaur C, Ling EA (2007) Microglial activation and its implications in the brain diseases. Curr Med Chem 14:1189–1197
14. Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55:310–318
15. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion—from mechanism to translation. Nat Med 17:1391–1401
16. Famakin B, Mou Y, Spatz M, Lawal M, Hallenbeck J (2012) Downstream toll-like receptor signaling mediates adaptor-specific cytokine expression following focal cerebral ischemia. J Neuroinflammation 9:174
17. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson’s disease. Proc Natl Acad Sci U S A 104:18754–18759
18. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, C. American Heart Association Statistics and S. Stroke Statistics (2014) Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 129:e28–e292
19. Gu JH, Ge JB, Li M, Wu F, Zhang W, Qin ZH (2012) Inhibition of NF-kappaB activation is associated with anti-inflammatory and anti-apoptotic effects of ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury. Eur J Pharm Sci: off J Eur Fed Pharm Sci 47:652–660
20. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132:344–362
21. Hou J, Wang J, Zhang P, Li D, Zhang C, Zhao H, Fu J, Wang B, Liu J (2012) Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway. Int Immunopharmacol 14:749–757
22. Huang CY, Fujimura M, Noshita N, Chang YY, Chan PH (2001) SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 21:163–173
23. Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H, Hara H (2010) Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia. Neuroscience 171:258–267
24. Iadecola C, Alexander M (2001) Cerebral ischemia and inflammation. Curr Opin Neurol 14:89–94
25. Iadecola C, Anrather J (2011) The immunology of stroke: from mechanisms to translation. Nat Med 17:796–808
26. Jaracz S, Malik S, Nakanishi K (2004) Isolation of ginkgolides a, B, C, J and bilobalide from G. biloba extracts. Phytochemistry 65:2897–2902
27. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, C. American Heart Association Stroke, N. Council on Cardiovascular, D. Council on Peripheral Vascular and C. Council on Clinical (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke J Cereb Cir 44:870–947
28. Jiang M, Li J, Peng Q, Liu Y, Liu W, Luo C, Peng J, Li J, Yung KK, Mo Z (2014) Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflammation 11:167
29. Jordan MS, Singer AL, Koretzky GA (2003) Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 4:110–116
30. Kacimi R, Giffard RG, Yenari MA (2011) Endotoxin-activated microglia injure brain derived endothelial cells via NF-kappaB, JAK-STAT and JNK stress kinase pathways. J Inflamm 8:7
31. Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441:431–436
32. Kaushal V, Schlichter LC (2008) Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J Neurosci: Off J Soc Neurosci 28:2221–2230
33. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115–122
34. Kleijnen J, Knipschild P (1992) Ginkgo biloba. Lancet 340:1136–1139
35. Ko HM, Jung HH, Seo KH, Kang YR, Kim HA, Park SJ, Lee HK, Im SY (2006) Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity. FEBS Lett 580:3006–3012
36. Lehnardt S, Lehmann S, Kaul D, Tschimmel K, Hoffmann O, Cho S, Krueger C, Nitsch R, Meisel A, Weber JR (2007) Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J Neuroimmunol 190:28–33
37. Liu YG, Li FJ, Wang J, Wang XD (2010) [Effects of ginkgolide B on inflammation induced by cerebral ischemia-reperfusion in rats]. Zhong yao cai Zhongyaocai. J Chin Med Mater 33:578–580
38. Luan H, Kan Z, Xu Y, Lv C, Jiang W (2013) Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. J Neuroinflammation 10:28
39. Lv M, Liu Y, Zhang J, Sun L, Liu Z, Zhang S, Wang B, Su D, Su Z (2011a) Roles of inflammation response in microglia cell through toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury. Neuroscience 176:162–172
40. Lv P, Fang W, Geng X, Yang Q, Li Y, Sha L (2011b) Therapeutic neuroprotective effects of ginkgolide B on cortex and basal ganglia in a rat model of transient focal ischemia. Eur J Pharm Sci: Off J Eur Fed Pharm Sci 44:235–240
41. Ma S, Liu H, Jiao H, Wang L, Chen L, Liang J, Zhao M, Zhang X (2012) Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca (2+) influx. Neurotoxicology 33:59–69
42. Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67:235–257
43. McDermott EP, O’Neill LA (2002) Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J Biol Chem 277:7808–7815
44. Moon JB, Lee CH, Park CW, Cho JH, Hwang IK, Yoo KY, Choi JH, Shin HC, Won MH (2009) Neuronal degeneration and microglial activation in the ischemic dentate gyrus of the gerbil. J Vet Med Sci Jpn Soc Vet Sci 71:1381–1386
45. Murray CJ, Lopez AD (1997) Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269–1276
46. Muzio M, Ni J, Feng P, Dixit VM (2013) Pillars article: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 1997 278:1612–1615 Journal of immunology, 190, 16–19
47. Nagy K, Domoki F, Bari F (2005) Ischemic preconditioning in the brain. Ideggyogyaszati szemle 58:305–313
48. Neubert M, Ridder DA, Bargiotas P, Akira S, Schwaninger M (2011) Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ 18:1521–1530
49. Neuhaus W, Burek M, Djuzenova CS, Thal SC, Koepsell H, Roewer N, Forster CY (2012) Addition of NMDA-receptor antagonist MK801 during oxygen/glucose deprivation moderately attenuates the upregulation of glucose uptake after subsequent reoxygenation in brain endothelial cells. Neurosci Lett 506:44–49
50. Ni Q, Wang J, Li EQ, Zhao AB, Yu B, Wang M, Huang CR (2011) Study on the protective effect of the mixture of Shengmai powder and Danshen decoction on the myocardium of diabetic cardiomyopathy in the rat model. Chin J Integr Med 17:116–125
51. Nishi T, Maier CM, Hayashi T, Saito A, Chan PH (2005) Superoxide dismutase 1 overexpression reduces MCP-1 and MIP-1 alpha expression after transient focal cerebral ischemia. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 25:1312–1324
52. O’Neill LA (2002) Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol 23:296–300
53. O’Neill LA (2003) The role of MyD88-like adapters in toll-like receptor signal transduction. Biochem Soc Trans 31:643–647
54. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E (2006) High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Phys Cell Phys 290:C917–C924
55. Peng SY, Liao WH, Nie ZG, Liu Y, Wang L, Wang F, Wang WJ (2010) [effect of ginkgolide B on the production of NO, IL-6 and RANTES from astrocytes]. Yao xue xue bao. Acta Pharm Sin 45:1103–1108
56. Pradillo JM, Fernandez-Lopez D, Garcia-Yebenes I, Sobrado M, Hurtado O, Moro MA, Lizasoain I (2009) Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J Neurochem 109:287–294
57. Qin X, Sun ZQ, Dai XJ, Mao SS, Zhang JL, Jia MX, Zhang YM (2012) Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation. Neurol Res 34:379–389
58. Qin X, Sun ZQ, Zhang XW, Dai XJ, Mao SS, Zhang YM (2013) TLR4 signaling is involved in the protective effect of propofol in BV2 microglia against OGD/reoxygenation. J Physiol Biochem 69:707–718
59. Ridder DA, Schwaninger M (2009) NF-kappaB signaling in cerebral ischemia. Neuroscience 158:995–1006
60. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, Matsumoto K, Takeuchi O, Akira S (2005) Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol 6:1087–1095
61. Schaller B, Graf R (2004) Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 24:351–371
62. Schwarzkopf TM, Koch KA, Klein J (2013) Neurodegeneration after transient brain ischemia in aged mice: beneficial effects of bilobalide. Brain Res 1529:178–187
63. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19:2668–2681
64. Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10–20
65. Son HY, Han HS, Jung HW, Park YK (2009) Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. J Pharmacol Sci 109:368–379
66. Sosna J, Voigt S, Mathieu S, Lange A, Thon L, Davarnia P, Herdegen T, Linkermann A, Rittger A, Chan FK, Kabelitz D, Schutze S, Adam D (2014) TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol life Sci: CMLS 71:331–348
67. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1–14
68. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP (2007) Pivotal role for neuronal toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A 104:13798–13803
69. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276:31332–31339
70. Vallabhapurapu S, Karin M (2009) Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27:693–733
71. van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG (2000) The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 48:1183–1194
72. Vieira M, Fernandes J, Carreto L, Anuncibay-Soto B, Santos M, Han J, Fernandez-Lopez A, Duarte CB, Carvalho AL, Santos AE (2014) Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol Dis 68:26–36
73. Vilhardt F (2005) Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37:17–21
74. Wang H, Cho CH (2010) Effect of NF-kappaB signaling on apoptosis in chronic inflammation-associated carcinogenesis. Curr Cancer Drug Targets 10:593–599
75. Wang XX, Shang YP, Chen JZ, Zhu JH, Guo XG, Sun J (2004) [Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood]. Yao xue xue bao = Acta Pharm Sin 39:656–660
76. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53–68
77. Wang X, Qin ZH, Shi H, Savitz SI, Qin AP, Jiang Y, Zhang HL (2008) Protective effect of Ginkgolids (A + B) is associated with inhibition of NIK/IKK/IkappaB/NF-kappaB signaling pathway in a rat model of permanent focal cerebral ischemia. Brain Res 1234:8–15
78. Wang F, Li H, Shi H, Sun B (2012a) Pro-apoptotic role of nuclear factor-kappaB in adriamycin-induced acute myocardial injury in rats. Mol Med Rep 5:400–404
79. Wang J, Hou J, Zhang P, Li D, Zhang C, Liu J (2012b) Geniposide reduces inflammatory responses of oxygen-glucose deprived rat microglial cells via inhibition of the TLR4 signaling pathway. Neurochem Res 37:2235–2248
80. Weinstein JR, Koerner IP, Moller T (2010) Microglia in ischemic brain injury. Future Neurol 5:227–246
81. Welz PS, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van Loo G, Pasparakis M (2011) FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477:330–334
82. Winters L, Winters T, Gorup D, Mitrecic D, Curlin M, Kriz J, Gajovic S (2013) Expression analysis of genes involved in TLR2-related signaling pathway: inflammation and apoptosis after ischemic brain injury. Neuroscience 238:87–96
83. Wong ET, Tergaonkar V (2009) Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential. Clin Sci 116:451–465
84. Wu X, Qian Z, Ke Y, Du F, Zhu L (2009) Ginkgolide B preconditioning protects neurons against ischaemia-induced apoptosis. J Cell Mol Med 13:4474–4483
85. Xia SH, Fang DC (2007) Pharmacological action and mechanisms of ginkgolide B. Chin Med J 120:922–928
86. Xu Y, Wang J, Song X, Wei R, He F, Peng G, Luo B (2016) Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by global cerebral ischemia/reperfusion injury in rats. Brain Res Bull 120:97–105
87. Yamaguchi K, K. S, Shibuya H, Irie K, Oishi I, Ueno N, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008–2011
88. Yin B, Xu Y, Wei RL, He F, Luo BY, Wang JY (2015) Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury. Brain Res 1609:63–71
89. Yun HJ, Yoon JH, Lee JK, Noh KT, Yoon KW, Oh SP, Oh HJ, Chae JS, Hwang SG, Kim EH, Maul GG, Lim DS, Choi EJ (2011) Daxx mediates activation-induced cell death in microglia by triggering MST1 signalling. EMBO J 30:2465–2476
90. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M (2005) Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab: Off J Int Soc Cereb Blood Flow Metab 25:30–40
91. Zhang P, Cox CJ, Alvarez KM, Cunningham MW (2009a) Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol 183:27–31
92. Zhang Q, Chen C, Lu J, Xie M, Pan D, Luo X, Yu Z, Dong Q, Wang W (2009b) Cell cycle inhibition attenuates microglial proliferation and production of IL-1beta, MIP-1alpha, and NO after focal cerebral ischemia in the rat. Glia 57:908–920
93. Zhang J, Yang J, Zhang C, Jiang X, Zhou H, Liu M (2012) Calcium antagonists for acute ischemic stroke. Cochrane Database Syst Rev 5:CD001928
94. Zhu GY, Zhu XL, Geng QX, Zhang X, Shao J (2004) [Change of peripheral blood monocytes derived macrophage scavenger receptors activity in patients with coronary heart disease, and the intervention effect of Ginkgo biloba extract]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui. Zhongguo Zhong yi yan jiu yuan zhu ban 24:1069–1072
95. Ziegler G, Harhausen D, Schepers C, Hoffmann O, Rohr C, Prinz V, Konig J, Lehrach H, Nietfeld W, Trendelenburg G (2007) TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 359:574–579
96. Zwagerman N, Plumlee C, Guthikonda M, Ding Y (2010) Toll-like receptor-4 and cytokine cascade in stroke after exercise. Neurol Res 32:123–126